CAPS and cryopyrin-associated periodic syndrome: For example, the inhibitors in CAPS that inhibit downstream pro-inflammatory cytokine also contribute to reducing the pathogenic effect of CAPS by blocking inflammasome-independent but CAPS-dependent pyroptosis released DAMPs that are produced to induce more CAPS-related pathological inflammation [313].